Please login to the form below

Not currently logged in
Email:
Password:

ALKS 3831

This page shows the latest ALKS 3831 news and features for those working in and with pharma, biotech and healthcare.

Alkermes’ new antipsychotic clears FDA advisory committee hurdle

Alkermes’ new antipsychotic clears FDA advisory committee hurdle

Alkermes’ experimental antipsychotic for schizophrenia and bipolar I disorder ALKS 3831 has cleared an US Food and Drug Administration (FDA) expert advisory committee review. ... ALKS 3831 is a combination of the established oral antipsychotic

Latest news

  • Troubled Alkermes eyes November OK for new antipsychotic Troubled Alkermes eyes November OK for new antipsychotic

    Review begins for potential schizophrenia and bipolar I disorder drug. The FDA has started its review of Alkermes’ experimental antipsychotic for schizophrenia and bipolar I disorder – ALKS 3831 – setting up a ... That left Alkermes more reliant on

  • Alkermes slumps as FDA turns down depression drug Alkermes slumps as FDA turns down depression drug

    Alkermes has been hit hard by the FDA’s rejection of antidepressant candidate ALKS 5461 - citing a lack of evidence that it was clinically effective. ... The setback for ALKS 5461 will leave Alkermes more reliant on a positive read-out for

  • Alkermes depression drug misses targets in phase III Alkermes depression drug misses targets in phase III

    If that occurs, Alkermes said bundling that dataset with a successful phase II trial and the FORWARD-4 results could be enough to build a marketing application for ALKS 56461. ... This is overcome by giving it alongside samidorphan. Samidorphan is also

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of certified medical illustrators creating animations that draw audiences into a world of suspense, excitement,...

Latest intelligence

patient diversity buckland
Patient diversity in clinical trials needs to be centre stage
By Danny Buckland...
Why empathy in digital patient recruitment is vital
This is where empathy mapping can be incredibly effective....
Top 10 ways that Medical Affairs teams can leverage the Impetus InSite Platform®
Some of the most popular and innovative ways of using our cutting-edge asynchronous and synchronous virtual tools for Medical Affairs teams....